Skip to main content
Evidence-based Complementary and Alternative Medicine : eCAM logoLink to Evidence-based Complementary and Alternative Medicine : eCAM
. 2026 Feb 17;2026:9801743. doi: 10.1155/ecam/9801743

Correction to “Metabolomics of the Protective Effect of Ampelopsis grossedentata and Its Major Active Compound Dihydromyricetin on the Liver of High‐Fat Diet Hamster”

PMCID: PMC12912759  PMID: 41709990

L. Fan. X. Qu, T. Yi, et al., “Metabolomics of the Protective Effect of Ampelopsis grossedentata and Its Major Active Compound Dihydromyricetin on the Liver of High‐Fat Diet Hamster,” Evidence-Based Complementary and Alternative Medicine, no. 2020 (2020): 1–15. https://doi.org/10.1155/2020/3472578.

In the article, several errors were identified in the notation of chemical structures shown in Figure 3. The corrected Figure 3 is as follows.

FIGURE 3.

FIGURE 3

Structures of dihydromyricetin and identified compounds isolated from Ampelopsis grossedentata.

TABLE 1.

List of original edition and corrections of the identified errors in the notation of chemical structures shown in Figure 3.

No. Original edition Corrections
1. No. 6. Apigenin Changed to No. 27
2. No. 7. Isopentenylbenzoic acid‐4‐O‐xyloosylglucoside Changed to Ampelopsin‐4′‐O‐β‐D‐glucopyranoside.
3. No. 8. Gallic acid Changed to No. 6
4. No. 11. Methyl gallate Changed to No. 9
5. No. 12. Calycosin‐7‐O‐β‐D‐glucoside Changed to No. 10
6. No. 13. Ethyl gallate Changed to No. 11
7. No. 14. Dihydromyricetin Changed to No. 12
8. No. 15. Grossedentataside Changed to No. 30
9. No. 16. Rutin Changed to No. 17
10. No. 17. Myricetin‐3‐O‐β‐D‐galactopyranoside Changed to No. 13
11. No. 19. Myricetin‐3′‐O‐β‐D‐xyloside Changed to No. 15
12. No. 20. Myricetrin Changed to No. 18 Myricitrin
13. No. 21. Quercetin‐3‐O‐β‐D‐glucoside Changed to No. 19
14. No. 22. Grossedentatasin Changed to No. 20
15. No. 24. Quercetin Changed to No. 28
16. No. 25. Emodin Changed to No. 22
17. No. 26. Dihydroquercetin Changed to No. 23
18. No. 27. Astragalin Changed to No. 24
19. No. 28. Kaempeerol‐3‐O‐glucorhamnoside Changed to No. 25
20. No. 29. Kaempferol Changed to No. 26
21. No. 30. Myricetin Changed to No. 16
22. Added No. 8. Isopentenylbenzoic acid‐4‐O‐xyloosylglucoside
23. Added No. 21. Quercetin‐3‐rhamnoside
24. Added No. 29. β‐Sitosterol
25. Added No. 31. Stigmasterol

We apologize for these errors.

Correction to “Metabolomics of the Protective Effect of Ampelopsis grossedentata and Its Major Active Compound Dihydromyricetin on the Liver of High‐Fat Diet Hamster”, Evidence‐Based Complementary and Alternative Medicine, 2026, 9801743, 3 pages, 2026. 10.1155/ecam/9801743


Articles from Evidence-based Complementary and Alternative Medicine : eCAM are provided here courtesy of Wiley

RESOURCES